CLINICAL_TRIALS
trial_result
· 2016-06-17
Clinical Trial Update: A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) [Phase 2]
Summary
Phase 2 study results evaluating the efficacy and safety of Vibegron (MK-4618) in adults with overactive bladder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Bladder, Overactive | Phase 2 | Status: COMPLETED | Results posted: 2016-06-17